Diabetes Care Devices Market is Projected to Reach USD 56.57 Billion Globally by 2030, Size, Share, Drivers, Key Growth, Challenges, Competitive Scenario and Opportunity Analysis

Increasing prevalence of diabetes is expected to contribute to this market's growth during the forecast period. As per the International Diabetes Federation Report for 2017, around 66.0 million people globally have diabetes, and it is projected to rise to 81.0 million by 2045


NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- "Diabetes Care Devices Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive environment are all dissected in detail in the research. This Diabetes Care Devices market analysis gives an examination of a range of segments that are relied upon to witness the quickest development amid the estimated forecast frame. The company profiles of all the key players and brands that are dominating the Diabetes Care Devices market with moves like product launches, joint ventures, mergers, and acquisitions which in turn is affecting the sales, import, export, revenue and CAGR values are mentioned in the report. A complete discussion about numerous market-related topics in this Diabetes Care Devices market research report is sure to aid the client in studying the market competitive landscape.

The data and information collected with the research is generally quite a huge and is also in a complex form. However, such intricate market insights are turned into simpler version with the help of proven tools and techniques to provide it to the end users. Estimations of CAGR values, market drivers and market restraints helps businesses decide upon several strategies. The use of proven tools such as SWOT analysis and Porter’s Five Forces analysis are very helpful in creating such a top-notch Diabetes Care Devices market research report. With the use of few steps or the combination of several steps, the process of generating Diabetes Care Devices market report is initiated with the expert advice.

Data Bridge Market Research analyses that the diabetes care devices market which is USD 29.02 billion in 2022, is expected to reach USD 56.57 billion by 2030, at a CAGR of 8.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Access to a Sample PDF of the Diabetes Care Devices Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-diabetes-care-devices-market

Diabetes care devices are the ones that is utilized to determine blood sugar levels in the body which is caused by insulin production. These care devices are provided to diabetic patients for real monitoring blood glucose levels and improve treatment for this chronic condition. Diabetes care gadgets are widely used to monitor diabetics' blood glucose levels. A continuous glucose monitor (CGM) is a medical device that tracks and monitors diabetes patients' blood glucose levels for the whole day. This wearable device will benefit the patients by supporting them in managing their glucose levels.

Several top manufacturers are focusing on many technological innovations and developing advanced products to gain extensive market share. As per the records of IDF, around 21,600 children are added to the type 1 diabetic population every year. As per these figures, diabetes accounts for around 9% of total healthcare expenditure globally. Numerous government initiatives, such as the National Service Framework (NSF) programme in the U.K., are improving services by setting national standards to increase the service quality and address variations in care. The various risk factors such as overweight, smoking, obesity, and high cholesterol levels are anticipated to boost the incidence of diabetes, thus fuelling the utmost need for diabetes devices.

The Global Market Is Analyzed in Depth in the Latest Study. Taking into account the current level of competition and its projected evolution over the next few years.

Rapidly increasing demands, a rise in industrialization, consumer awareness, growing sectors, and technical improvements are fueling the expansion of the Diabetes Care Devices Industry. Sales and revenue in this sector have increased at an exponential rate. The market's size and growth are both expected to increase thanks to the factors driving the market's expansion over the projected period.

Leading businesses in the worldwide Diabetes Care Devices market are investing heavily in R&D in order to build a larger client base and expand their share of the market by reintroducing improved products to consumers. All of the companies' strategy, as well as their financial health, revenue, gross margin, and growth rate, are detailed in the study.

The Diabetes Care Devices Market is Dominated by Firms Such as

  • Abbott (U.S.)
  • PHC Holdings Corporation (Japan)
  • WellDoc, Inc (India)
  • Sanofi (France)
  • Dexcom, Inc (U.S.)
  • DarioHealth Corp. (U.S.)
  • Medtronic (Ireland)
  • B. Braun SE (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Insulet Corporation (U.S.)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • Tidepool (U.S.)
  • Medtronic (Ireland)
  • Tandem Diabetes Care (U.S.)
  • LifeScan (U.S.)
  • AgaMatrix (U.S.)
  • Glooko Inc. (U.S.)
  • DarioHealth (Israel)

Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-diabetes-care-devices-market

Recent Development

  • In 2021, Medtronic received a CE mark for its InPen smart insulin pen and Guardian 4 sensor for better diabetes management.
  • In 2021, Medtronic launched the Medtronic Extended infusion set in very few countries. This advancement doubles the time an infusion set can be worn, allowing users to safely continue on insulin pump therapy with lesser interruptions and insertions while adding feasibility and comfort to their diabetes management routine.
  • In 2020, Novo Nordisk announced the acquisition of Emisphere Technologies, a drug delivery technology company. The acquisition is expected to help Novo Nordisk gain a competitive edge in the oral antidiabetic market

Opportunities for Key Players:

  • Government initiatives and Increased awareness campaigns

Numerous government initiatives and awareness campaigns are also pushing the market growth. For instance, the UK DESMOND education programme is a structured patient education and management programme for patients suffering from newly diagnosed type 2 diabetes. Its aim is to help people identify early health risks. There has also been a rise in government funding for healthcare. As per the International Diabetes Federation Diabetes-related healthcare spending is rapidly growing. Furthermore, Bigfoot collaborated with Abbott and received clearance from the U.S. FDA in 2021 for the Bigfoot Unity Diabetes Management system. This first-of-its-kind system2 holds smartpen caps for disposable insulin pens - injection devices that people with diabetes use to inject insulin - that integrate with Abbott's world-leading FreeStyle Libre 2 technology. Diabetes device demand is projected to be boosted by many supportive initiatives and increasing awareness during the forecast period.

Key Market Segments Covered in Diabetes Care Devices Industry Research

By Product Type

  • Testing Strips
  • Blood Glucose Meters
  • Self-monitoring Blood Glucose Meters
  • Continuous Blood Glucose Monitoring Devices
  • Lancets
  • Others
  • Insulin Delivery Devices

By Device Type

  • Self-monitoring
  • Diagnostic

By Delivery Type

  • Pumps
  • Pen
  • Injectors
  • Cartridges in Reusable pens
  • Disposable Pens
  • Jet Injectors

By Distribution Channel

  • Institutional Sales
  • Hospitals
  • Clinics
  • Others
  • Retail Sales
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Key Industry Drivers:

  • Rising Prevalence of Diabetes

The increasing prevalence of diabetes is expected to contribute to this market's growth during the forecast period. As per the International Diabetes Federation Report for 2017, around 66.0 million people globally have diabetes, and it is projected to rise to 81.0 million by 2045. The top five diabetic countries in Global are the United Kingdom, France, Germany, Spain, and Italy. In North America, it has been witnessed that there are more than 29 million diabetic patients, and this number is projected to increase to 34 million by 2027. The U.S. alone recorded more than 26 million diabetes patients in 2021. This boosts the market growth.

  • Increase in obesity

Obesity is one of the top causes of diabetes in the general population. According to the records of WHO, around 50% of the global population was overweight in 2014, with more than 20% of the population obese. Obesity is more prevalent in men. Risk factors, such as the increasing occurrence of obesity, are directly associated to the increasing prevalence of diabetes. Consequently, the diabetes device market is increasing.

Browse Detailed Summary of Research Report @ https://www.databridgemarketresearch.com/reports/global-diabetes-care-devices-market

Diabetes Care Devices Market Regional Analysis/Insights:

The countries covered in the diabetes care devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Global in Global, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the diabetes care devices market due to the presence of well-developed healthcare infrastructure and favourable reimbursement policies in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the rising incidence of cancer such as esophagus, liver, bladder, pancreas, and others, increased presence of major manufacturers across the U.S. Additionally, technological advancements and rising foreign investment.

Some of the Most Important Questions Scrutinized in the Business Intelligence Report:

  • What are the key growth parameters for this global market during the forecast period?
  • Which key players are expected to hold the largest market share over the forecast period?
  • Who are the leading vendors and manufacturers in this market?
  • What are the key strategies adopted by leading players in the market for business development and geographical expansion?
  • Which end-use industries can trigger high demand in the market over the forecast period?
  • What are the key segments in this market?
  • Which regional player will anticipate leading the global market in terms of size?
  • What is the impact of novel coronavirus pandemic?
  • Which obstacles must new players overcome in order to occupy a major position?

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Diabetes Care Devices Market: Regulations
  6. Market Overview
  7. Global Diabetes Care Devices Market, By Product Type
  8. Global Diabetes Care Devices Market, By Device Type
  9. Global Diabetes Care Devices Market, By Delivery Type
  10. Global Diabetes Care Devices Market, By Distribution Channel
  11. Global Diabetes Care Devices Market, By Region
  12. Global Diabetes Care Devices Market: Company Landscape
  13. SWOT Analyses
  14. Company Profile
  15. Questionnaires
  16. Related Reports

Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-diabetes-care-devices-market

Explore More Reports:

  • Syringes Market, By Material (Plastic Syringes, Glass Syringes), Type (General Syringes, Specialized Syringes), Design (Single Chamber Prefilled Syringes, Dual Chamber Prefilled Chamber, Customized Prefilled Syringes), Usability (Disposable Syringes, Sterilizable/ Reusable Syringes), End Users (Hospitals, Ambulatory Centers, Clinics, Community Healthcare, Others), Distribution Channel (Retail, Direct Tenders), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-syringes-market
  • Diabetes Pen Market, By Product Type (Insulin Pens, Insulin Pen Needle), Usage (Reusable Pens, Disposable Pens), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-diabetes-pen-market
  • Diabetes Treatments Market, By Type of Diabetes (Type-1, Type-2), Product (Insulin, Oral Hypoglycemic Drugs, Non-Insulin Injectable Drugs), Devices (Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-diabetes-treatments-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com